A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of two ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") today announced the ...

The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several ...

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ongoing studies are needed.

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

CGRP” medications, the drug didn’t meet some analysts’ expectations in mid-stage testing but still convinced Lundbeck to ...

The poster will be available on the Resources & Publications section of the Company’s website following the presentation.

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For ...

The first experimental use of chemotherapy was conducted in 1942 using nitrogen mustard to treat non-Hodgkin lymphoma, 1,2 marking the beginning of modern chemotherapy development, the transition from ...